Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | IBRX | HALO | ||
| Company | Apellis Pharmaceuticals Inc | Immunitybio Inc | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.62 | 8.72 | 39.56 | ||
| High | 47.74 | 9.12 | 40.74 | ||
| Low | 46.10 | 8.25 | 38.88 | ||
| Last | 47.49 | 8.97 | 39.82 | ||
| Change | +1.44 | +0.43 | +0.52 | ||
| % Change | +3.13% | +5.04% | +1.32% | ||
| Volume | 1,020,600 | 9,810,000 | 832,100 | ||
| 20-Day Average Volume | 1,579,890 | 12,036,190 | 866,825 | ||
| Previous Close | 46.05 | 8.54 | 39.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 50.26 | 6.15 | 38.99 | ||
| 20-Day Raw Stochastic | 47.23% | 73.10% | 55.44% | ||
| 20-Day Relative Strength | 40.18% | 66.33% | 53.64% | ||
| Weighted Alpha | -20.17 | +16.67 | +22.84 | ||
| Today's Opinion | 56% Sell | 100% Buy | 40% Buy | ||
| Previous Opinion | 56% Sell | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 8% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.92% since 04/25/24 | +75.54% since 04/25/24 | +3.54% since 04/25/24 | ||
| Low | 38.22 on 04/30/24 | 4.92 on 04/26/24 | 37.97 on 04/30/24 | ||
| High | 50.98 on 04/26/24 | 10.53 on 04/29/24 | 40.74 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -14.74% since 04/02/24 | +70.21% since 04/02/24 | -1.51% since 04/02/24 | ||
| Low | 38.22 on 04/30/24 | 4.73 on 04/12/24 | 37.73 on 04/19/24 | ||
| High | 58.12 on 04/04/24 | 10.53 on 04/29/24 | 41.50 on 04/05/24 | ||
| 3-Month | |||||
| %Chg | -24.09% since 02/02/24 | +116.67% since 02/02/24 | +18.23% since 02/02/24 | ||
| Low | 38.22 on 04/30/24 | 3.37 on 02/23/24 | 33.15 on 02/05/24 | ||
| High | 71.90 on 02/26/24 | 10.53 on 04/29/24 | 42.64 on 03/13/24 | ||
| 6-Month | |||||
| %Chg | -3.71% since 11/02/23 | +142.43% since 11/02/23 | +16.26% since 11/02/23 | ||
| Low | 38.22 on 04/30/24 | 2.66 on 11/10/23 | 33.15 on 02/05/24 | ||
| High | 73.80 on 01/09/24 | 10.53 on 04/29/24 | 42.82 on 12/14/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,760,252 | 6,072,717 | 5,059,291 | ||
| Shares Outstanding, K | 121,294 | 677,003 | 127,054 | ||
| Annual Sales | 396,590,000 | 620,000 | 829,250,000 | ||
| Annual Net Income | -528,630,000 | -583,200,000 | 281,590,000 | ||
| Last Quarter Sales | 146,380,000 | 140,000 | 230,040,000 | ||
| Last Quarter Net Income | -88,580,000 | -233,390,000 | 85,390,000 | ||
| 60-Month Beta | 0.97 | 1.16 | 1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/27/24 | -0.19 on 03/19/24 | 0.82 on 02/20/24 | ||
| Latest Earnings Date | 05/07/24 | 05/09/24 | 05/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.41 | ||